课题基金 / 基金详情

项目摘要

项目成果

SHERINE S CHAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Mitochondria have their own closed circular genome. Mitochondrial DNA (mtDNA) has a 10 times greater rate of mutation than nuclear DNA. As DNA polymerase gamma is the only known DNA polymerase within the mitochondrion, it is essential for faithful replication, proofreading and repair of mtDNA. The overall goal of this proposal is to understand the fundamental mechanisms of exonuclease activity of DNA polymerase gamma in mtDNA metabolism, and to define its role in disease. Based on the following, we hypothesize that altered exonucleolytic activity of DNA polymerase gamma leads to mitochondrial dysfunction and disease. First, mutations in the exonuclease domain of DNA polymerase gamma cause devastating mitochondrial diseases. Second, polymerase domain mutations in DNA polymerase gamma that cause an error-prone phenotype can be ameliorated by functional exonuclease. Third, mouse models of proofreading-deficient DNA polymerase gamma show enhanced mtDNA mutations and accelerated ageing phenotype with reduced lifespan. Fourth, nucleoside reverse transcriptase inhibitors (NRTIs) used to control HIV infection induce mitochondrial dysfunction by inhibiting DNA polymerase gamma. Mitochondrial diseases can be caused by genetic and environmental factors. Unfortunately, there is no cure or no effective long-term treatment. As more diseases show mitochondrial defects, it is imperative that we understand how defects lead to disease. We will investigate the role of the exonuclease domain of DNA polymerase gamma in maintaining the integrity of mtDNA by: AIM 1. To investigate the underiying consequences of disease mutations within the exonuclease domain, and how these give rise to mitochondrial dysfunction and disease. AIM 2. To identify the critical regions within the exonuclease domain that are involved in proofreading, and to determine how efficientiy the exonuclease excises incorporated NRTIs, as well as nucleotides incorrectly incorporated opposite miscoding lesions in the template (such as 8oxoG, a marker of oxidative stress), and environmental DNA lesions (such as those caused by benzo[a]pyrene).
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bbabio.2008.10.007
发表时间: 2009-05
期刊: BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
影响因子: 4.3
作者: [Chan, Sherine S. L., Copeland, William C.]
通讯作者: Copeland, William C.
Mitochondrial disorders of DNA polymerase γ dysfunction: from anatomic to molecular pathology diagnosis.
DNA聚合酶γ功能障碍的线粒体疾病:从解剖学到分子病理学诊断。
DOI: 10.5858/2010-0356-rar.1
发表时间: 2011
期刊: Archives of pathology & laboratory medicine
影响因子: 4.6
作者: [Zhang,Linsheng, Chan,SherineSL, Wolff,DaynnaJ]
通讯作者: Wolff,DaynnaJ
A Vitamin K analog countermeasure for organophosphate poisoning
  • 批准号:
    10602913
  • 项目类别:
  • 资助金额:
    $29.83万
  • 财政年份:
    2023
  • 负责人:
    SHERINE S CHAN
  • 依托单位:
Development of new anti-epilepsy treatments targeting cellular energetics through mitochondrial modulation with optimal pharmacokinetics and toxicity profiles
  • 批准号:
    9760014
  • 项目类别:
  • 资助金额:
    $75.0万
  • 财政年份:
    2016
  • 负责人:
    SHERINE S CHAN
  • 依托单位:
Adverse Actions of Stimulants on Embryonic Development and Energetics
海外基金